Journal article

Phase II trial of anti-idiotypic p53 peptides (Pentrys) plus granulocyte-macrophage colony-stimulating factor in patients with hormone-refractory prostate cancer

Ian D Davis, Guy Toner, Adam Broad, Louise M Campano, Mark Rosenthal

Asia-Pacific Journal of Clinical Oncology | BLACKWELL PUBLISHING | Published : 2007

DOI: 10.1111/j.1743-7563.2007.00101.x

University of Melbourne Researchers

Keywords

Clinical-Trial
Tumor Suppressor Protein P53
Prostate Neoplasms
Phage Display
Molecular Mimicry
Cancer Vaccines
Melanoma
Generation
Life Sciences & Biomedicine
Vaccine
Immunization
Oncology
Science & Technology
Radical Prostatectomy
Antibodies
Immune-Responses
Wild
Peptides